Product
NNC0480 0389 + Semaglutide A
1 clinical trial
2 indications
Indication
Diabetes MellitusIndication
Type 2Clinical trial
A Study to Investigate the Pharmacokinetics of Semaglutide and NNC0480-0389 When Subcutaneously Administered as a Co-formulation or as Separate Injections in Healthy ParticipantsStatus: Completed, Estimated PCD: 2022-01-05